metaraminol has been researched along with Endometriosis in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Endometriosis: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Long, Q | 1 |
| Liu, X | 1 |
| Qi, Q | 1 |
| Guo, SW | 1 |
1 other study available for metaraminol and Endometriosis
| Article | Year |
|---|---|
Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β2.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals | 2016 |